ClinicalTrials.gov
ClinicalTrials.gov Menu

MRI Screening for Auditory Pathway Malformations in Visually Impaired Children (DIMAVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02896738
Recruitment Status : Recruiting
First Posted : September 12, 2016
Last Update Posted : February 8, 2018
Sponsor:
Information provided by (Responsible Party):
Fondation Ophtalmologique Adolphe de Rothschild

Brief Summary:
This pilot study aims to assess the interest to add an auditory pathway morphological analysis during the MRI exploration of visual pathway in visually impaired children.

Condition or disease
Visual Impairment

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Actual Study Start Date : September 2015
Estimated Primary Completion Date : September 2019
Study Completion Date : September 2019



Primary Outcome Measures :
  1. number of patients with Auditory Pathway Malformation [ Time Frame: baseline ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Visually impaired children undergoing MRI exploration.
Criteria

Inclusion Criteria:

  • age < 18 years old
  • visual impairment
  • MRI scheduled to explore their visual impairment
  • parents' informed consent for participation in the study

Exclusion Criteria:

  • tumoral origin for the visual impairment
  • no health insurance coverage

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02896738


Contacts
Contact: Laurence Salomon, MD +33 1 48 03 64 31 lsalomon@fo-rothschild.fr

Locations
France
Fondation Ophtalmologique Adolphe de Rothschild Recruiting
Paris, France, 75019
Contact: Laurence Salomon, MD    +33 1 48 03 64 31    lsalomon@fo-rothschild.fr   
Sponsors and Collaborators
Fondation Ophtalmologique Adolphe de Rothschild
Investigators
Principal Investigator: Louise Boyeldieu, MD Fondation OPH A de Rothschild

Responsible Party: Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier: NCT02896738     History of Changes
Other Study ID Numbers: LBU_2015_6
First Posted: September 12, 2016    Key Record Dates
Last Update Posted: February 8, 2018
Last Verified: February 2018

Additional relevant MeSH terms:
Vision Disorders
Vision, Low
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Eye Diseases
Signs and Symptoms